Identifying selective PDHK inhibitors using coupled tensor matrix completion and experimental validation
Open Access
- 24 November 2024
- journal article
- research article
- Published by Springer Nature in Discover Artificial Intelligence
- Vol. 4 (1) , 1-8
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Deucravacitinib: First ApprovalDrugs, 2022
- GCHN-DTI: Predicting drug-target interactions by graph convolution on heterogeneous networksMethods, 2022
- Structure-based drug design of novel and highly potent pyruvate dehydrogenase kinase inhibitorsBioorganic & Medicinal Chemistry, 2021
- Fragment-based lead discovery to identify novel inhibitors that target the ATP binding site of pyruvate dehydrogenase kinasesBioorganic & Medicinal Chemistry, 2021
- Improving Measures of Chemical Structural Similarity Using Machine Learning on Chemical–Genetic InteractionsJournal of Chemical Information and Modeling, 2021
- Identification of Novel Resorcinol Amide Derivatives as Potent and Specific Pyruvate Dehydrogenase Kinase (PDHK) InhibitorsJournal of Medicinal Chemistry, 2019
- Application of Off-Rate Screening in the Identification of Novel Pan-Isoform Inhibitors of Pyruvate Dehydrogenase KinaseJournal of Medicinal Chemistry, 2017
- Discovery and Optimization of 4,5-Diarylisoxazoles as Potent Dual Inhibitors of Pyruvate Dehydrogenase Kinase and Heat Shock Protein 90Journal of Medicinal Chemistry, 2014
- Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivityNature Biotechnology, 2011
- Features of similarity.Psychological Review, 1977